The Comparison of Tricuspid Replacement and Repair in Patients With Combined Heart Valve Disease

NCT01246141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2010-11-23

No results posted yet for this study

Summary

Functional tricuspid regurgitation is common in patients with heart valve disease, replacement and repair both can correct this anomaly. However, there is no data to address which one can bring more benefits to these patients with combined heart valve disease. The investigators retrospectively review patients with two or more heart valve disease and functional tricuspid regurgitation, and assess its long term outcomes.

Conditions

  • Tricuspid Valve Regurgitation

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • zhang jinzhou, MD · Xijing Hospital

Eligibility

Min Age
21 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-01-31
Primary Completion
2009-12-31
Completion
2010-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01246141 on ClinicalTrials.gov